Health Can a New Hepatitis B Drug Finally Let Some Patients Stop Lifelong Treatment? ByThe WIN Desk October 22, 2026October 22, 2026
Health Can the FDA’s New Jemperli Approval Help Some Rectal Cancer Patients Avoid Surgery? ByThe WIN Desk October 20, 2026October 20, 2026
Health Why Is the FDA Rethinking Rare-Disease Drug Approvals—and What Changes for Patients? ByThe WIN Desk October 16, 2026October 16, 2026
